Healthcare
Ageing, chronic diseases push APAC medtech towards $132b by 2030
Ageing, chronic diseases push APAC medtech towards $132b by 2030
Despite this, few companies in the region have scaled globally.
9 hours ago
India rolls out terminology, drug registry
The terminology service will be set up for consistent interpretation and exchange of health data.
1 day ago
AI-powered microscopy software poised for $3.09b surge by 2031
North America accounted for the largest market share in 2025.
1 day ago
China’s healthcare defies Hang Seng slump with 0.9% gain
Investor sentiment, however, weakened during the second quarter.
1 day ago
Abu Dhabi and MIT Koch advance AI-driven cancer research
It includes physician-scientist fellowships.
2 days ago
Biomarkers market to top $112b by 2031 on drug discovery demand
Consumables held the largest share at 73.4% in 2025.
2 days ago
AU’s Royal North Shore expands cancer trials access with new unit
It was funded by a $13.8m (AU$20m) gift.
2 days ago
Taiwan's NTUH, EVA Air launch in-flight doctor programme
Physicians recommend scheduling a consultation four to six weeks before departure.
2 days ago
Singapore's CGH cuts desflurane, slashes emissions
Desflurane usage fell to just 1.44 litres in 2025 from 242 litres in 2019.
2 days ago
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Hong Kong’s listing pathways provide issuers with flexibility and access to a sophisticated investor base.
2 days ago
Seoul St. Mary's Hospital, Dankook University centres team up on health tech prototypes
They will reduce prototyping time and costs.
2 days ago
Indonesia anchors Longevity 5.0 amidst regional stem cell gaps
Borderless Healthcare links regenerative medicine with clinics, resorts, and home-based wellness.
5 days ago
RESILIA valves reshape lifetime care planning
Durability data and transcatheter reintervention options are influencing treatment decisions across Asia-Pacific
5 days ago
Tissue valve uptake hinges on data and diagnosis
Durability evidence is shifting younger patient use whilst awareness remains Australia’s main adoption barrier.
5 days ago
RESILIA data widens tissue valve options for younger patients
Awareness and price still slow adoption as durability evidence challenges mechanical valve trade-offs.
5 days ago
GERD device market to hit $1.9b as reflux care goes minimally invasive
India emerged as the fastest-growing market in APAC.
5 days ago
Fertility sensors race to $2.80b by 2033 as at-home testing takes off
Asia Pacific could emerge as the fastest-growing region.
5 days ago
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential